Trial reportEuropean journal of applied physiology2026
Low-intensity exercise reduces negative affect via circulating endocannabinoid dynamics in healthy young adults.
Trial report in European journal of applied physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeMental health disorders represent a critical challenge in modern society, necessitating the establishment of effective management strategies. Low-intensity exercise is thought to improve mood by activating endocannabinoids (eCBs), but the underlying mechanisms remain unclear. This study aimed to test the hypothesis that an increase in circulating eCB levels during low-intensity exercise contributes to a reduction in negative affect.
methodsIn a randomized crossover trial, 30 healthy participants completed two 60-min cycling exercise sessions at two intensities: low (30% heart rate reserve [HRR]) and moderate (50% HRR). Plasma concentrations of N-arachidonoylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG) were measured at four points: pre-exercise (baseline), during exercise (10 and 30 min), and immediately post-exercise (60 min). Mood was assessed before and after each session using the Physical Activity Affect Scale.
resultsPlasma eCB concentrations did not change uniformly and showed substantial inter-individual variability in both conditions. Although low-intensity exercise significantly reduced negative affect, this change was not significantly correlated with the cumulative plasma AEA and 2-AG during the exercise. Notably, a repeated-measures correlation (rmcorr) revealed a significant negative correlation between plasma AEA concentrations and negative affect across pre- and post-exercise time points in the low-intensity condition.
conclusionLow-intensity exercise improved negative affect despite inconsistent aggregate changes in eCBs, specifically AEA and 2-AG. Dynamic intra-individual changes in plasma AEA, rather than cumulative concentrations, appear to drive this mental health benefit. These findings suggest a novel mechanism implicating exercise-induced AEA dynamics in mental health improvement. CLINICAL
trial registrationUMIN-CTR UMIN000060566, registered 4 February 2026, retrospectively registered.
Indexed as
Identifiers
42489728What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.